18F-RO-7016970

N/A

Report date: 2025/01/26 15:18:09

Base Information

Drug Name18F-RO-7016970
Drug Alias Namefibroblast activation protein radiotracer (AbbVie/F Hoffmann-La Roche/National Cancer Centre of Singapore)18F-RO-7016970
ClassificationRadiation-emitting products
Mechanisms of ActionFibroblast activation protein alpha modulators
TargetsProlyl endopeptidase FAP
Therapy Area/IndicationsPulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSingaporeSwitzerland
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A